Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study

BACKGROUND: Digoxin use was shown to be associated with an increased risk of cardiovascular events in atrial fibrillation (AF). We hypothesized that digoxin may affect cardiovascular risk by increasing platelet activation. METHODS AND RESULTS: Post hoc analysis of a prospective study of anticoagulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastori, Daniele, Carnevale, Roberto, Nocella, Cristina, Bartimoccia, Simona, Novo, Marta, Cammisotto, Vittoria, Piconese, Silvia, Santulli, Maria, Vasaturo, Fortunata, Violi, Francesco, Pignatelli, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404445/
https://www.ncbi.nlm.nih.gov/pubmed/30571484
http://dx.doi.org/10.1161/JAHA.118.009509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404445/
https://www.ncbi.nlm.nih.gov/pubmed/30571484
http://dx.doi.org/10.1161/JAHA.118.009509

Ejemplares similares